March 28th 2025
The FDA has approved Visby Medical’s at-home sexually transmitted infection test, allowing women to screen for chlamydia, gonorrhea, and trichomoniasis without a prescription.
The Sexual Health and Wellness Consortium features a variety of informative videos, articles, podcasts, polls, and quizzes to help you better care for your patients as they navigate their sexual health and wellness journey.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
Satellite Symposia at the 2025 Oncology Nursing Society Congress
April 11-12, 2025
Register Now!
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Local Estrogen Treatment Improves Sexual Satisfaction in Postmenopausal Women and their Partners
June 17th 2013After treating vaginal atrophy with local estrogens, sexual satisfaction for postmenopausal women and their male partners improves, according to the results of a survey published online in the journal Menopause.
Read More
Osphena Approved by FDA to Treat Dyspareunia
February 27th 2013Osphena (ospemifene) has been approved by the FDA to treat dyspareunia. This is the first non-steroidal estrogen available for women with dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy (VVA) that is common during menopause.
Read More
Managing Postmenopausal Symptoms With Nonpharmacological Therapies
February 1st 2013Certain herbal and complementary medicines may be a valuable treatment option for women with postmenopausal symptoms, according to a new review outlining the advantages and limitations of the available treatments of postmenopausal symptoms.
Read More
More Countries Report Cephalosporin-Resistant Gonorrhea
June 18th 2012The number of cases of cephalosporin-resistant gonorrhea is increasing, according to a recent report issued by the World Health Organization. Neisseria gonorrhoeae, the bacteria that causes the infection, has already developed resistance to other common antibiotics, and cephalosporins have become the last line of defense against the infection.
Read More
ACOG: Region Should Factor Into Chlamydia Screening Guidelines For Women Over Age 25
May 14th 2012Women over the age of 25 may still need to be screened for Chlamydia trachomatis (CT) according to research released at the American Congress of Obstetricians and Gynecologists’ (ACOG) Annual Clinical Meeting.
Read More
How to Screen for Intimate Partner Violence: Tools from ACOG
February 29th 2012More than one third of women in the United States will experience some form of intimate partner violence (IPV) in their lifetime. The consequences of IPV can be lifelong and include emotional trauma, long-term physical impairment, chronic health problems, and even death.
Read More
Genital Wart Management: A Partnership Between Physician and Patient
With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.
Read More